High Performance Lipid Nanoparticle Production System

Lipid nanoparticles (LNPs) are a form of new dosage form for delivering drugs, including anticancer agents and vaccines. A highly controlled production system is needed to produce high quality LNPs, and the existing production systems suffer from a few drawbacks, such as lack of variable control and automated functions. Dionamix will employ their technologies and develop a new production system to improve LNP manufacturing. The interns from University of British Columbia will help validate the new system for the LNP production. The project will expand Dionamix’ product portfolio and potentially generate new revenue and jobs.

Faculty Supervisor:

Shyh-Dar Li

Student:

Partner:

Dionamix Scientific Inc.

Discipline:

Engineering

Sector:

Life Sciences (not health); Nanotechnology; Pharmaceuticals

University:

The University of British Columbia

Program: